Literature DB >> 5061067

Hazard of combining allopurinol and thiopurine.

A Berns, S Rubenfeld, W T Rymzo, J J Calabro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5061067     DOI： 10.1056/nejm197203302861321

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

Review 1.  Immunosuppressive Medications.

Authors:  Alexander C Wiseman
Journal:  Clin J Am Soc Nephrol       Date:  2015-07-13       Impact factor: 8.237

2.  Combination of thiopurines and allopurinol: adverse events and clinical benefit in IBD.

Authors:  Shail M Govani; Peter D R Higgins
Journal:  J Crohns Colitis       Date:  2010-03-21       Impact factor: 9.071

3.  Azathioprine-related myelosuppression in a patient homozygous for TPMT*3A.

Authors:  Pooja Budhiraja; Mordecai Popovtzer
Journal:  Nat Rev Nephrol       Date:  2011-06-28       Impact factor: 28.314

Review 4.  Pharmacological targeting of allergen-specific T lymphocytes.

Authors:  Peter A Tauber; Winfried F Pickl
Journal:  Immunol Lett       Date:  2017-03-18       Impact factor: 3.685

Review 5.  Immunosuppression and Kidney Transplantation.

Authors:  Jeanne Kamal; Alden Doyle
Journal:  Handb Exp Pharmacol       Date:  2022

Review 6.  Use of allopurinol with low-dose 6-mercaptopurine in inflammatory bowel disease to achieve optimal active metabolite levels: a review of four cases and the literature.

Authors:  T N Witte; A L Ginsberg
Journal:  Can J Gastroenterol       Date:  2008-02       Impact factor: 3.522

Review 7.  Clinical pharmacology and pharmacogenetics of thiopurines.

Authors:  Srikumar Sahasranaman; Danny Howard; Sandip Roy
Journal:  Eur J Clin Pharmacol       Date:  2008-05-28       Impact factor: 3.064
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.